[Federal Register Volume 81, Number 191 (Monday, October 3, 2016)]
[Notices]
[Page 68019]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-23719]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[CDC-2015-0034, Docket Number NIOSH 233-A]


NIOSH List of Antineoplastic and Other Hazardous Drugs in 
Healthcare Settings 2016

AGENCY: National Institute for Occupational Safety and Health (NIOSH), 
Centers for Disease Control and Prevention (CDC), Department of Health 
and Human Services (HHS).

ACTION: Notice of issuance of final guidance publication.

-----------------------------------------------------------------------

SUMMARY: The National Institute for Occupational Safety and Health 
(NIOSH) of the Centers for Disease Control and Prevention (CDC), 
announces the availability of the following publication: NIOSH List of 
Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2016 
[2016-161].

ADDRESSES: This document may be obtained at the following link: http://www.cdc.gov/niosh/docs/2016-161/.

FOR FURTHER INFORMATION CONTACT: Barbara A. MacKenzie, NIOSH Division 
of Applied Research and Technology, 1090 Tusculum Avenue, MS C-26, 
Cincinnati, OH 45226. 513-533-8132 (not a toll free number), 
[email protected].

    Dated: September 27, 2016.
Frank Hearl,
Chief of Staff, National Institute for Occupational Safety and Health, 
Centers for Disease Control and Prevention.
[FR Doc. 2016-23719 Filed 9-30-16; 8:45 am]
 BILLING CODE 4163-19-P